{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:22:00Z","timestamp":1789237320045,"version":"build-2803163510"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.molimm.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T17:34:22Z","timestamp":1550511262000},"page":"56-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":169,"special_numbering":"C","title":["Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli"],"prefix":"10.1016","volume":"108","author":[{"given":"Mohammad Reza","family":"Asadi Karam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2019.02.007_bib0005","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1128\/IAI.00315-16","article-title":"Lipopolysaccharide domains modulate urovirulence","volume":"84","author":"Aguiniga","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0010","article-title":"Antibiotic resistance in uropathogenic E. Coli strains isolated from non-hospitalized patients in pakistan","volume":"8","author":"Ali","year":"2014","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0015","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1128\/IAI.01010-09","article-title":"UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073","volume":"78","author":"Allsopp","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0020","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1128\/JB.01264-12","article-title":"Functional heterogeneity of the UpaH autotransporter protein from uropathogenic Escherichia coli","volume":"194","author":"Allsopp","year":"2012","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/IAI.05322-11","article-title":"Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073","volume":"80","author":"Allsopp","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0030","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/IAI.00076-06","article-title":"Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine","volume":"75","author":"Alteri","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000586","article-title":"Mucosal immunization with iron receptor antigens protects against urinary tract infection","volume":"5","author":"Alteri","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molimm.2019.02.007_bib0040","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.4049\/jimmunol.178.8.4717","article-title":"Cutting edge: Tlr5-\/- mice are more susceptible to Escherichia coli urinary tract infection","volume":"178","author":"Andersen-Nissen","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1084550","article-title":"Intracellular bacterial biofilm-like pods in urinary tract infections","volume":"301","author":"Anderson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.02.007_bib0050","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.vaccine.2012.12.059","article-title":"Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice","volume":"31","author":"Asadi Karam","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.02.007_bib0055","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1099\/jmm.0.032482-0","article-title":"Characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco","volume":"60","author":"Barguigua","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.diagmicrobio.2008.12.001","article-title":"Mechanisms of resistance and mobility among multidrug-resistant CTX-M\u2013producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America","volume":"63","author":"Baudry","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0924-8579(02)00106-1","article-title":"Prevention of recurrent urinary tract infections with immuno-active E. Coli fractions: a meta-analysis of five placebo-controlled double-blind studies","volume":"19","author":"Bauer","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.molimm.2019.02.007_bib0070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.eururo.2004.12.009","article-title":"Multicenter UTI study group: a long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections","volume":"47","author":"Bauer","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0075","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrneph.2015.105","article-title":"Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis","volume":"11","author":"Becknell","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/518897","article-title":"Combined multilocus sequence typing and O serogrouping distinguishes Escherichia coli subtypes associated with infant urosepsis and\/or meningitis","volume":"196","author":"Bidet","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0085","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/681473","article-title":"Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage","volume":"2012","author":"Bien","year":"2012","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/599839","article-title":"A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli","volume":"200","author":"Billips","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/erv.12.36","article-title":"Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine","volume":"11","author":"Brumbaugh","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.molimm.2019.02.007_bib0100","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/IAI.00470-13","article-title":"Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection","volume":"81","author":"Brumbaugh","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0105","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1086\/598524","article-title":"Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance","volume":"199","author":"Buckles","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0110","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1098\/rstb.2011.0206","article-title":"Chaperone-usher pathways: diversity and pilus assembly mechanism","volume":"367","author":"Busch","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond., B, Biol. Sci."},{"key":"10.1016\/j.molimm.2019.02.007_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1824-7288-37-3","article-title":"Antimicrobial resistance among Escherichia coli that cause childhood community-acquired urinary tract infections in Northern Italy","volume":"37","author":"Caracciolo","year":"2011","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.molimm.2019.02.007_bib0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fcimb.2013.00080","article-title":"Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans","volume":"3","author":"Caza","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nchembio.242","article-title":"Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation","volume":"5","author":"Cegelski","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molimm.2018.03.001","article-title":"A novel multi-peptide subunit vaccine admixed with AddaVax adjuvant produces significant immunogenicity and protection against Proteus mirabilis urinary tract infection in mice model","volume":"96","author":"Choubini","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1758-2229.12019","article-title":"The C lermont Escherichia coli phylo\u2010typing method revisited: improvement of specificity and detection of new phylo\u2010groups","volume":"5","author":"Clermont","year":"2013","journal-title":"Environ. Microbiol. Rep."},{"key":"10.1016\/j.molimm.2019.02.007_bib0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0065-2660(05)54011-2","article-title":"DNA vaccine","volume":"54","author":"Cui","year":"2005","journal-title":"Adv. Genet."},{"key":"10.1016\/j.molimm.2019.02.007_bib0145","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/600385","article-title":"Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women","volume":"200","author":"Czaja","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0150","first-page":"25","article-title":"Isolation and characterization of multi drug resistant uropathogenic Escherichia coli from urine sample of Urinary tract infected patients","volume":"2","author":"Dash","year":"2012","journal-title":"Int. J. Life Sci. Pharma Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1099\/jmm.0.46177-0","article-title":"Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains","volume":"55","author":"Dashti","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0160","first-page":"BR136","article-title":"Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens","volume":"13","author":"De Francesco","year":"2007","journal-title":"Med. Sci. Monit."},{"issue":"Suppl 2","key":"10.1016\/j.molimm.2019.02.007_bib0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2362.2008.01986.x","article-title":"Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli","volume":"38","author":"Dhakal","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.02.007_bib0170","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1128\/IAI.01269-06","article-title":"Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli","volume":"75","author":"Durant","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.diagmicrobio.2013.11.011","article-title":"Prevalence of antibiotic resistance in US hospitals","volume":"78","author":"Edelsberg","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.6116279","article-title":"Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control","volume":"214","author":"Eisenstein","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.02.007_bib0185","article-title":"Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli","volume":"58","author":"Ejrnaes","year":"2011","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.molimm.2019.02.007_bib0190","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1371\/journal.ppat.0030100","article-title":"Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli","volume":"3","author":"Eto","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molimm.2019.02.007_bib0195","article-title":"Microbial susceptibility, virulence factors, and plasmid profiles of uropathogenic Escherichia coli strains isolated from children in Jahrom, Iran","volume":"15","author":"Farshad","year":"2012","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.molimm.2019.02.007_bib0200","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12879-015-1282-4","article-title":"Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies","volume":"15","author":"Fasugba","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/eji.200535149","article-title":"Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection","volume":"36","author":"Fischer","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7774\/cevr.2014.3.2.185","article-title":"Cellular immunity survey against urinary tract infection using pVAX\/fimH cassette with mammalian and wild type codon usage as a DNA vaccine","volume":"3","author":"Fooladi","year":"2014","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0220","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.molimm.2019.02.007_bib0230","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1099\/jmm.0.058354-0","article-title":"Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa","volume":"62","author":"Fust\u00e9","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0235","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/IAI.01222-10","article-title":"Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection","volume":"79","author":"Garcia","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0240","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/IAI.73.1.627-631.2005","article-title":"Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin","volume":"73","author":"Goluszko","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0245","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000281988","article-title":"Treatment of bacterial infections of the female urinary tract by immunization of the patients","volume":"42","author":"Grischke","year":"1987","journal-title":"Urol. Int."},{"key":"10.1016\/j.molimm.2019.02.007_bib0250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-135-1-200107030-00012","article-title":"Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections","volume":"135","author":"Gupta","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.molimm.2019.02.007_bib0255","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1128\/IAI.70.8.4539-4546.2002","article-title":"Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells","volume":"70","author":"Guyer","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.intimp.2015.05.027","article-title":"Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model","volume":"28","author":"Habibi","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0265","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molimm.2014.12.008","article-title":"Intranasal immunization with fusion protein MrpH.FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis","volume":"64","author":"Habibi","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0270","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/apm.12523","article-title":"Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis","volume":"124","author":"Habibi","year":"2016","journal-title":"APMIS"},{"key":"10.1016\/j.molimm.2019.02.007_bib0275","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.micpath.2017.07.037","article-title":"Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection","volume":"110","author":"Habibi","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.molimm.2019.02.007_bib0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7883\/yoken.JJID.2015.652","article-title":"Epidemiology of multidrug resistant uropathogenic Escherichia coli in Iran: a systematic review and meta-analysis","volume":"70","author":"Hadifar","year":"2017","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0285","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1128\/IAI.00337-07","article-title":"Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection","volume":"75","author":"Hagan","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001187","article-title":"Escherichia coli global gene expression in urine from women with urinary tract infection","volume":"6","author":"Hagan","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molimm.2019.02.007_bib0295","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/iai.61.5.2108-2115.1993","article-title":"Specificity of S fimbriae on recombinant Escherichia coli: preferential binding to gangliosides expressing NeuGc alpha (2-3) Gal and NeuAc alpha (2-8) NeuAc","volume":"61","author":"Hanisch","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0300","first-page":"39","article-title":"Resistance patterns of urinary isolates in a tertiary Indian hospital","volume":"19","author":"Hasan","year":"2007","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"10.1016\/j.molimm.2019.02.007_bib0305","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/IAI.68.10.5816-5823.2000","article-title":"Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice","volume":"68","author":"Haversen","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0310","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.revmedmi.0000131427.13353.7f","article-title":"Multiple resistance in Gram-negative bacteria","volume":"15","author":"Hawkey","year":"2004","journal-title":"Rev. Med. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0315","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1128\/MMBR.68.4.692-744.2004","article-title":"Type V protein secretion pathway: the autotransporter story","volume":"68","author":"Henderson","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.molimm.2019.02.007_bib0320","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1385\/IR:33:1:083","article-title":"Effects of flagellin on innate and adaptive immunity","volume":"33","author":"Honko","year":"2005","journal-title":"Immunol. Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0325","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","author":"Hooton","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.02.007_bib0330","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.juro.2006.11.093","article-title":"Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial","volume":"177","author":"Hopkins","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0335","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(17)30108-1","article-title":"Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial","volume":"17","author":"Huttner","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0340","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.4.1.80","article-title":"Virulence factors in Escherichia coli urinary tract infection","volume":"4","author":"Johnson","year":"1991","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molimm.2019.02.007_bib0345","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/IAI.73.2.965-971.2005","article-title":"The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection","volume":"73","author":"Johnson","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0350","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5347(01)62142-6","article-title":"Susceptibility of immunodeficient gene-knockout mice to urinary tract infection","volume":"161","author":"Jones-Carson","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0355","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.0308125100","article-title":"Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis","volume":"101","author":"Justice","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.02.007_bib0360","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molimm.2012.11.002","article-title":"Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli","volume":"54","author":"Karam","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0365","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.biologicals.2016.06.006","article-title":"Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens","volume":"44","author":"Karam","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.molimm.2019.02.007_bib0370","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1128\/IAI.68.6.3541-3547.2000","article-title":"Receptor structure for F1C fimbriae of uropathogenic Escherichia coli","volume":"68","author":"Khan","year":"2000","journal-title":"Infec. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0375","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3346\/jkms.2010.25.3.435","article-title":"A prospective multi-center trial of Escherichia coli extract for the prophylactic treatment of patients with chronically recurrent cystitis","volume":"25","author":"Kim","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.molimm.2019.02.007_bib0380","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.chom.2009.05.011","article-title":"Bacterial adhesins in host-microbe interactions","volume":"5","author":"Kline","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molimm.2019.02.007_bib0385","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1128\/IAI.00376-06","article-title":"Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis","volume":"74","author":"Klumpp","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0390","first-page":"215","article-title":"Immunostimulatory activity of the vaccine used in the treatment of recurrent urinary infections","volume":"100","author":"Koukalova","year":"1999","journal-title":"II. Bratisl. Med. J."},{"key":"10.1016\/j.molimm.2019.02.007_bib0395","first-page":"246","article-title":"Immunomodulation of recurrent urinary tract infections with Urvakol vaccine","volume":"100","author":"Koukalova","year":"1999","journal-title":"Bratisl. Med. J."},{"key":"10.1016\/j.molimm.2019.02.007_bib0400","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00510527","article-title":"Urinary antibody response after immunisation with a vaccine against urinary tract infection","volume":"17","author":"Kruze","year":"1989","journal-title":"Urol. Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0405","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00296534","article-title":"Protection by a polyvalent vaccine against challenge infection and pyelonephritis","volume":"20","author":"Kruze","year":"1992","journal-title":"Urol. Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0410","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/pgmj.2004.023036","article-title":"Urinary tract infections: new insights into a common problem","volume":"81","author":"Kucheria","year":"2005","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.molimm.2019.02.007_bib0415","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.0607898104","article-title":"Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract","volume":"104","author":"Lane","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.02.007_bib0420","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.276.5312.607","article-title":"Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination","volume":"276","author":"Langermann","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.02.007_bib0425","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/315258","article-title":"Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli","volume":"181","author":"Langermann","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.molimm.2019.02.007_bib0430","article-title":"Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections","volume":"183","author":"Langermann","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0435","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1172\/JCI22832","article-title":"Renal-associated TLR2 mediates ischemia\/reperfusion injury in the kidney","volume":"115","author":"Leemans","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.02.007_bib0440","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1574-6976.2007.00078.x","article-title":"Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology","volume":"31","author":"Lemonnier","year":"2007","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.molimm.2019.02.007_bib0445","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11908-008-0081-0","article-title":"Complicated urinary tract infections","volume":"10","author":"Lichtenberger","year":"2008","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.molimm.2019.02.007_bib0450","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1128\/JB.01744-06","article-title":"Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli","volume":"189","author":"Lloyd","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0455","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/189016","article-title":"Current and potential applications of host-defense peptides and proteins in urology","volume":"2015","author":"Lo","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.molimm.2019.02.007_bib0460","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005574","article-title":"Estrogen supports urothelial defense mechanisms","volume":"5","author":"Luthje","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molimm.2019.02.007_bib0465","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fcimb.2017.00241","article-title":"Metabolic adaptations of uropathogenic E. coli in the urinary tract","volume":"7","author":"Mann","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0470","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/039463200501800306","article-title":"Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections","volume":"18","author":"Marinova","year":"2005","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0475","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1128\/IAI.01086-06","article-title":"Protease activity, secretion, cell entry, cytotoxicity, and cellular targets of secreted autotransporter toxin of uropathogenic Escherichia coli","volume":"74","author":"Maroncle","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0480","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.femsle.2005.08.028","article-title":"Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. Coli (UPEC) pathotypes?","volume":"252","author":"Marrs","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.molimm.2019.02.007_bib0485","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0732-8893(01)00254-1","article-title":"Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America)","volume":"40","author":"Mathai","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0490","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.molmed.2016.09.003","article-title":"Urinary tract infection: pathogenesis and outlook","volume":"22","author":"McLellan","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molimm.2019.02.007_bib0495","doi-asserted-by":"crossref","first-page":"13468","DOI":"10.1073\/pnas.1606324113","article-title":"Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection","volume":"113","author":"Mike","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.02.007_bib0500","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.peptides.2007.10.001","article-title":"The antimicrobial peptide tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model","volume":"28","author":"Minardi","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.molimm.2019.02.007_bib0505","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3855\/jidc.1703","article-title":"Drug resistance, serotypes, and phylogenetic groups among uropathogenic Escherichia coli including O25-ST131 in Mexico city","volume":"5","author":"Molina-L\u00f3pez","year":"2011","journal-title":"J. Infet. Dev. Ctries."},{"key":"10.1016\/j.molimm.2019.02.007_bib0510","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1073\/pnas.0915077107","article-title":"Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli","volume":"107","author":"Moriel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.02.007_bib0515","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/j.1365-2672.2008.04115.x","article-title":"Antibiotherapy and pathogenesis of uncomplicated UTI: difficult relationships","volume":"106","author":"Moura","year":"2009","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0520","first-page":"449","article-title":"Multidrug-resistance and extended Spectrum beta-Lactamase production in uropathogenic E. Coli which were isolated from hospitalized patients in Kolkata, India","volume":"7","author":"Mukherjee","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0525","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1462-5822.2002.00193.x","article-title":"Adhesion and entry of uropathogenic Escherichia coli","volume":"4","author":"Mulvey","year":"2002","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0530","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.282.5393.1494","article-title":"Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli","volume":"282","author":"Mulvey","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.02.007_bib0535","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.17514","article-title":"Virulence genes and antimicrobial resistance pattern in uropathogenic Escherichia coli isolated from hospitalized patients in Kashan, Iran","volume":"8","author":"Neamati","year":"2015","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0540","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00010-12","article-title":"FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections","volume":"3","author":"Nesta","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.molimm.2019.02.007_bib0545","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrurol.2010.101","article-title":"Host-pathogen interactions in urinary tract infection","volume":"7","author":"Nielubowicz","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0550","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/jb.160.2.691-695.1984","article-title":"Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71","volume":"160","author":"Nowicki","year":"1984","journal-title":"J. Bacteriol."},{"issue":"Suppl 1","key":"10.1016\/j.molimm.2019.02.007_bib0555","article-title":"Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness","volume":"183","author":"Nowicki","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0560","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s004670000493","article-title":"Recurrence and follow-up after urinary tract infection under the age of 1 year","volume":"16","author":"Nuutinen","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0565","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.UTI-0013-2012","article-title":"Drug and vaccine development for the treatment and prevention of urinary tract infections","volume":"4","author":"O\u2019Brien","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.molimm.2019.02.007_bib0570","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/iai.59.3.1153-1161.1991","article-title":"Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB\/c mouse model of pyelonephritis","volume":"59","author":"O\u2019Hanley","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0575","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jmii.2015.08.005","article-title":"Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico","volume":"50","author":"Paniagua-Contreras","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.molimm.2019.02.007_bib0580","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI113395","article-title":"Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis","volume":"81","author":"Parkkinen","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.02.007_bib0585","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fmicb.2013.00048","article-title":"\"Stormy waters ahead\": global emergence of carbapenemases","volume":"4","author":"Patel","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0590","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molimm.2019.02.007_bib0595","first-page":"206","article-title":"In vitro antimicrobial activity of several antimicrobial agents against Escherichia coli isolated from community-acquired uncomplicated urinary tract infections","volume":"17","author":"Pignanelli","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.molimm.2019.02.007_bib0600","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1073\/pnas.0606795103","article-title":"Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria","volume":"103","author":"Pinkner","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.02.007_bib0605","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2958.1998.01061.x","article-title":"Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili","volume":"30","author":"Pratt","year":"1998","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0610","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2362.2008.02004.x","article-title":"TLR\u2010and CXCR1\u2010dependent innate immunity: insights into the genetics of urinary tract infections","volume":"38","author":"Ragnarsdottir","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.02.007_bib0615","doi-asserted-by":"crossref","first-page":"21259","DOI":"10.1074\/jbc.M611502200","article-title":"Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled","volume":"282","author":"Reigstad","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.02.007_bib0620","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M400967200","article-title":"MEK is a key modulator for TLR5-induced interleukin-8 and MIP3alpha gene expression in non-transformed human colonic epithelial cells","volume":"279","author":"Rhee","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.02.007_bib0625","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1128\/IAI.69.10.6515-6519.2001","article-title":"Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model","volume":"69","author":"Rippere-Lampe","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0630","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1128\/IAI.69.6.3954-3964.2001","article-title":"Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli","volume":"69","author":"Rippere-Lampe","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0635","doi-asserted-by":"crossref","first-page":"11889","DOI":"10.1073\/pnas.91.25.11889","article-title":"The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract","volume":"91","author":"Roberts","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.02.007_bib0640","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/01.ju.0000116123.05160.43","article-title":"Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein","volume":"171","author":"Roberts","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0645","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(06)70599-0","article-title":"The worldwide emergence of plasmid-mediated quinolone resistance","volume":"6","author":"Robicsek","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0650","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1128\/IAI.71.12.7164-7169.2003","article-title":"The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate","volume":"71","author":"Russo","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0655","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1016\/j.vaccine.2007.01.100","article-title":"A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate","volume":"25","author":"Russo","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.02.007_bib0660","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.vaccine.2008.10.082","article-title":"Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine","volume":"27","author":"Russo","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.02.007_bib0665","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"Saade","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.molimm.2019.02.007_bib0670","first-page":"389","article-title":"Isolation and antibiotic susceptibility of E. coli from urinary tract infections in a tertiary care hospital","volume":"30","author":"Sabir","year":"2014","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.molimm.2019.02.007_bib0675","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/524662","article-title":"Preventing hospital-acquired urinary tract infection in the United States: a national study","volume":"46","author":"Saint","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0680","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.imlet.2005.05.004","article-title":"Salmonella flagellin, a microbial target of the innate and adaptive immune system","volume":"101","author":"Salazar-Gonzalez","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2019.02.007_bib0685","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/jac\/dku282","article-title":"Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients","volume":"69","author":"Sanchez","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molimm.2019.02.007_bib0690","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/AAC.02897-15","article-title":"Antibiotic resistance among urinary isolates from female outpatients in the United States in 2003 and 2012","volume":"60","author":"Sanchez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.molimm.2019.02.007_bib0695","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/318847","article-title":"Molecular characterization of the Escherichia coli FimH adhesin","volume":"183","author":"Schembri","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0700","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/IAI.71.3.1470-1480.2003","article-title":"CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli","volume":"71","author":"Schilling","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0705","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-5347(17)35648-3","article-title":"Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study","volume":"150","author":"Schulman","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0710","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijmm.2007.05.009","article-title":"Flagella allow uropathogenic Escherichia coli ascension into murine kidneys","volume":"298","author":"Schwan","year":"2008","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0715","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/IAI.05339-11","article-title":"Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection","volume":"79","author":"Schwartz","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0720","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jgar.2018.03.006","article-title":"Distribution of extended-spectrum \u03b2-Lactam, quinolone, and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran","volume":"14","author":"Shahbazi","year":"2018","journal-title":"J. Glob. Antimicrob. Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0725","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/ped.12949","article-title":"Antimicrobial activity of lactobacillus strains against uropathogens","volume":"58","author":"Shim","year":"2016","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.molimm.2019.02.007_bib0730","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/IAI.01000-09","article-title":"Waging war against uropathogenic Escherichia coli: winning back the urinary tract","volume":"78","author":"Sivick","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0735","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.4049\/jimmunol.0902386","article-title":"The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection","volume":"184","author":"Sivick","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0740","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.molimm.2019.02.007_bib0745","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eursup.2016.04.002","article-title":"Improved classification of urinary tract infection: future considerations","volume":"15","author":"Smelov","year":"2016","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.molimm.2019.02.007_bib0750","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.00075-08","article-title":"Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice","volume":"76","author":"Smith","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0755","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1128\/IAI.02848-14","article-title":"Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli","volume":"83","author":"Smith","year":"2015","journal-title":"Infect. Immun."},{"issue":"Suppl 2","key":"10.1016\/j.molimm.2019.02.007_bib0760","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2362.2008.02005.x","article-title":"Innate and adaptive immune responses in the urinary tract","volume":"38","author":"Song","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.02.007_bib0765","first-page":"5","article-title":"Adhesive pili in UTI pathogenesis and drug development","author":"Spaulding","year":"2016","journal-title":"Pathogens"},{"key":"10.1016\/j.molimm.2019.02.007_bib0770","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.05621-11","article-title":"Fimbrial profiles predict virulence of uropathogenic E. coli strains: contribution of Ygi and Yad fimbriae","author":"Spurbeck","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0775","first-page":"1228","article-title":"Binding characteristics of S fimbriated Escherichia coli to isolated brain microvascular endothelial cells","volume":"145","author":"Stins","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0780","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/CMR.00016-09","article-title":"Plasmid-mediated quinolone resistance: a multifaceted threat","volume":"22","author":"Strahilevitz","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molimm.2019.02.007_bib0785","first-page":"3","article-title":"Virulence and fitness determinants of uropathogenic Escherichia coli","author":"Subashchandrabose","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.molimm.2019.02.007_bib0790","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/1439-7633(20011203)2:12<915::AID-CBIC915>3.0.CO;2-M","article-title":"Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli","volume":"2","author":"Svensson","year":"2001","journal-title":"Chembiochem"},{"key":"10.1016\/j.molimm.2019.02.007_bib0795","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.phrp.2015.08.002","article-title":"Phenotypic assays to determine virulence factors of uropathogenic Escherichia coli (UPEC) isolates and their correlation with antibiotic resistance pattern","volume":"6","author":"Tabasi","year":"2015","journal-title":"Osong Public Health Res. Perspect."},{"key":"10.1016\/j.molimm.2019.02.007_bib0800","first-page":"DC01","article-title":"Genotypic characterization of virulence factors in Escherichia coli isolated from patients with acute cystitis, pyelonephritis and asymptomatic bacteriuria","volume":"10","author":"Tabasi","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0805","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0810","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1128\/IAI.05169-11","article-title":"Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli","volume":"79","author":"Tchesnokova","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0815","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3389\/fmicb.2017.01566","article-title":"Uropathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies","volume":"8","author":"Terlizzi","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0820","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI119623","article-title":"Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection","volume":"100","author":"Thankavel","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.02.007_bib0825","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.176.5.3080","article-title":"Antigen-specific responses accelerate bacterial clearance in the bladder","volume":"176","author":"Thumbikat","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0830","article-title":"Plasmid transfer capacities of multi-resistant UPEC clinical isolates in biofilms","volume":"28","author":"Tong","year":"2017","journal-title":"Biomed. Res."},{"key":"10.1016\/j.molimm.2019.02.007_bib0835","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2016.10.018","article-title":"Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women","volume":"207","author":"Torella","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0840","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1128\/IAI.69.10.6179-6185.2001","article-title":"TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse","volume":"69","author":"Torres","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0845","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0022-5347(01)64671-8","article-title":"Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial","volume":"157","author":"Uehling","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0850","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/318839","article-title":"Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial","volume":"183","author":"Uehling","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.02.007_bib0855","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/01.ju.0000075094.54767.6e","article-title":"Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections","volume":"170","author":"Uehling","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0860","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/IAI.01952-06","article-title":"Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract","volume":"75","author":"Ulett","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0865","first-page":"155","article-title":"Effectiveness and tolerability of short course co-trimoxazole, norfloxacin and levofloxacin in bacteriological cure of uncomplicated urinary tract infection in outpatient setting. An open label, parallel group, randomized controlled trial","volume":"23","author":"Vachhani","year":"2015","journal-title":"Infez. Med."},{"key":"10.1016\/j.molimm.2019.02.007_bib0870","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1128\/JB.00122-08","article-title":"UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli","volume":"190","author":"Valle","year":"2008","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0875","first-page":"525","article-title":"Toll-like receptors and renal bacterial infections","volume":"31","author":"Vandewalle","year":"2008","journal-title":"Chang Gung Med. J."},{"key":"10.1016\/j.molimm.2019.02.007_bib0880","doi-asserted-by":"crossref","first-page":"e00066","DOI":"10.1128\/mBio.00066-11","article-title":"Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract","volume":"2","author":"Vigil","year":"2011","journal-title":"MBio"},{"key":"10.1016\/j.molimm.2019.02.007_bib0885","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/IAI.05713-11","article-title":"The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia","volume":"80","author":"Vigil","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0890","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/cid\/ciw396","article-title":"Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens","volume":"63","author":"Walker","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.molimm.2019.02.007_bib0895","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2362.2008.02006.x","article-title":"Current concepts of molecular defence mechanisms operative during urinary tract infection","volume":"38","author":"Weichhart","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.02.007_bib0900","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1099\/mic.0.039024-0","article-title":"Autotransporters of Escherichia coli: a sequence-based characterization","volume":"156","author":"Wells","year":"2010","journal-title":"Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0905","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.75.103004.142545","article-title":"Biosynthesis and assembly of capsular polysaccharides in Escherichia coli","volume":"75","author":"Whitfield","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.molimm.2019.02.007_bib0910","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1046\/j.1365-2958.1999.01276.x","article-title":"Structure, assembly and regulation of expression of capsules in Escherichia coli","volume":"31","author":"Whitfield","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0915","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/IAI.00174-10","article-title":"A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice","volume":"78","author":"Wieser","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0920","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijmm.2011.09.012","article-title":"First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS)","volume":"302","author":"Wieser","year":"2012","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0925","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yexmp.2008.03.007","article-title":"Origins and virulence mechanisms of uropathogenic Escherichia coli","volume":"85","author":"Wiles","year":"2008","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0930","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1128\/IAI.73.11.7657-7668.2005","article-title":"Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization","volume":"73","author":"Wright","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.02.007_bib0935","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/j.1462-5822.2007.00952.x","article-title":"Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili","volume":"9","author":"Wright","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0940","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.ki.5000119","article-title":"Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells","volume":"69","author":"Yang","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2019.02.007_bib0945","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.1109893","article-title":"TLR11 activation of dendritic cells by a protozoan profilin-like protein","volume":"308","author":"Yarovinsky","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.02.007_bib0950","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1517\/13543784.2016.1161024","article-title":"Therapies in early development for the treatment of urinary tract inflammation","volume":"25","author":"Zacche","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.molimm.2019.02.007_bib0955","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1126\/science.1094351","article-title":"A toll-like receptor that prevents infection by uropathogenic bacteria","volume":"303","author":"Zhang","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.02.007_bib0960","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.mib.2013.09.007","article-title":"On the essentiality of lipopolysaccharide to Gram-negative bacteria","volume":"16","author":"Zhang","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.007_bib0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095864","article-title":"Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland","volume":"9","author":"Zurfluh","year":"2014","journal-title":"PLoS One"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018306357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018306357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:31:03Z","timestamp":1758979863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018306357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":193,"alternative-id":["S0161589018306357"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2019.02.007","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}